Top Story

Serum metabolites may serve as biomarker for early lung cancer detection

November 26, 2014

Serum metabolite profiles significantly differed between patients with stage I to III non–small cell lung cancer and at-risk adults without lung cancer, a finding that suggests metabolites offer promise as a potential lung cancer biomarker, according to study results presented at CHEST 2014.

“Our results showed that patients with lung cancer have altered metabolic processes,” researcher Peter J. Mazzone, MD, FCCP, director of the lung cancer program for the Respiratory Institute at Cleveland Clinic, said in a press release. “This information could lead to the development of a diagnostic biomarker for the early detection of lung cancer.”

In the Journals

Total-body photography may reduce melanoma worry in patients with atypical mole syndrome

November 26, 2014
The use of total-body digital photography may reduce concerns about melanoma development among patients with atypical mole syndrome, according to study results.Molly S
In the Journals

Researchers identify factors associated with hypocalcemia after thyroidectomy

November 25, 2014
A low postoperative intact parathyroid hormone level, female gender and presence of malignant neoplasm all independently predicted hypocalcemia after total…
In the Journals

Combined-modality treatment effective for muscle-invasive bladder cancer

November 25, 2014
Patients with muscle-invasive bladder cancer who underwent bladder-preserving combined-modality therapy experienced disease-specific survival comparable to that…
In the JournalsPerspective

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related neuroendocrine…
More News Headlines »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan